In financial year 2023, iX Biopharma Limited generated revenue of 5.2 million Singapore dollars from its specialty pharmaceutical segment. This segment focuses on the development, manufacturing, and sale of pharmaceutical products.
Revenue of iX Biopharma Limited for specialty pharmaceutical segment from financial years 2016 to 2023 (in 1,000 Singapore dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Members of EFPIA's pharmaceutical exports and imports 1990-2022
- Premium Statistic Members of EFPIA's pharmaceutical market value 2000-2022
- Premium Statistic Research and development in European pharmaceutical industry by country 2021
- Basic Statistic Olon worldwide revenue 2016-2021
- Basic Statistic Olon company profit 2016-2021
- Basic Statistic Dipharma Francis: profit 2016-2022
- Basic Statistic Dipharma Francis revenue 2016-2022
- Basic Statistic Average number of outstanding shares of Sanofi 2009-2023
- Basic Statistic Basic earnings per share of Sanofi 2009-2023
- Basic Statistic Total assets of Bausch Health 2011-2023
About the region
10
- Premium Statistic Export value of vaccines for human medicine Singapore 2012-2021
- Premium Statistic Import value of vaccines for human medicine Singapore 2012-2021
- Premium Statistic Export value of medicaments Singapore 2013-2022
- Premium Statistic Import value of medicaments Singapore 2013-2022
- Premium Statistic Import value of pharmaceutical products Singapore 2013-2022
- Premium Statistic Export value of pharmaceutical products Singapore 2013-2022
- Premium Statistic Number of employees in the pharmaceutical industry Singapore 2000-2023
- Premium Statistic Value added per worker in the pharmaceutical industry Singapore 2000-2023
- Premium Statistic Value added by the pharmaceutical industry Singapore 2014-2023
- Premium Statistic StarHub Limited's total revenue FY 2016-2022
Selected statistics
10
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
10
- Basic Statistic Market share of generics in European countries 2021
- Basic Statistic Top 10 medical cannabis companies in Canada in 2019, by number of patents
- Premium Statistic Value of pharmaceuticals sold in Italy 2011-2022
- Premium Statistic Top pharmacies in Colombia as of 2015, by sales
- Premium Statistic Sales of top multinational pharmaceutical companies in China in Q1 2011
- Basic Statistic Visited pharmacy websites during the coronavirus lockdown in Spain January to March
- Premium Statistic Vaccine revenue for statutory health insurance Germany 2006-2020, by illness
- Basic Statistic Savings through generic drug usage in the U.S., by age group share 2022
- Basic Statistic Net income of Bausch Health 2011-2023
- Premium Statistic Value of pharmaceutical drugs imports in Algeria 2013-2015
Related statistics
10
- Premium Statistic Genting Singapore Ltd revenue FY 2012-2022
- Premium Statistic Number of clinical trials approved Singapore 2017-2023
- Premium Statistic Number of licenses for health product manufacturers approved Singapore 2017-2022
- Premium Statistic Number of licenses for health product importers approved Singapore 2017-2022
- Premium Statistic Number of licenses for health product exporters approved Singapore 2017-2023
- Premium Statistic Number of licenses for health product wholesalers approved Singapore 2017-2022
- Premium Statistic Total revenue Changi Airport FY2013-FY2023
- Basic Statistic Operating revenue of Singtel Ltd FY 2016-2023
- Premium Statistic Revenue distribution of Starhub Limited FY 2022
- Premium Statistic EBITDA margin of Singtel Singapore 2019-2020
Further related statistics
9
- Net revenue from investment banking at Goldman Sachs 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Net revenue from investing and lending at Goldman Sachs 2009-2021
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- R&D expenditure in U.S. biotechnology 2009-2010 by type
Further Content: You might find this interesting as well
Statistics
- Net revenue from investment banking at Goldman Sachs 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Net revenue from investing and lending at Goldman Sachs 2009-2021
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- R&D expenditure in U.S. biotechnology 2009-2010 by type
iX Biopharma. (September 18, 2023). Revenue of iX Biopharma Limited for specialty pharmaceutical segment from financial years 2016 to 2023 (in 1,000 Singapore dollars) [Graph]. In Statista. Retrieved May 13, 2024, from https://www.statista.com/statistics/1198330/ix-biopharma-revenue-for-specialty-pharmaceutical-segment/
iX Biopharma. "Revenue of iX Biopharma Limited for specialty pharmaceutical segment from financial years 2016 to 2023 (in 1,000 Singapore dollars)." Chart. September 18, 2023. Statista. Accessed May 13, 2024. https://www.statista.com/statistics/1198330/ix-biopharma-revenue-for-specialty-pharmaceutical-segment/
iX Biopharma. (2023). Revenue of iX Biopharma Limited for specialty pharmaceutical segment from financial years 2016 to 2023 (in 1,000 Singapore dollars). Statista. Statista Inc.. Accessed: May 13, 2024. https://www.statista.com/statistics/1198330/ix-biopharma-revenue-for-specialty-pharmaceutical-segment/
iX Biopharma. "Revenue of Ix Biopharma Limited for Specialty Pharmaceutical Segment from Financial Years 2016 to 2023 (in 1,000 Singapore Dollars)." Statista, Statista Inc., 18 Sep 2023, https://www.statista.com/statistics/1198330/ix-biopharma-revenue-for-specialty-pharmaceutical-segment/
iX Biopharma, Revenue of iX Biopharma Limited for specialty pharmaceutical segment from financial years 2016 to 2023 (in 1,000 Singapore dollars) Statista, https://www.statista.com/statistics/1198330/ix-biopharma-revenue-for-specialty-pharmaceutical-segment/ (last visited May 13, 2024)
Revenue of iX Biopharma Limited for specialty pharmaceutical segment from financial years 2016 to 2023 (in 1,000 Singapore dollars) [Graph], iX Biopharma, September 18, 2023. [Online]. Available: https://www.statista.com/statistics/1198330/ix-biopharma-revenue-for-specialty-pharmaceutical-segment/